We are live on ! Find out more
EC

Euclidean Capital Portfolio holdings

AUM $440M Turnover 9.09%
1-Year Est. Return 28.33%
This Fund
S&P 500
This Quarter Est. Return
+9.15%
1 Year Est. Return
+28.33%
3 Year Est. Return
+79.73%
5 Year Est. Return
-17.94%
10 Year Est. Return
–
AUM
$440M
AUM Growth
+$47.5M
Cap. Flow
+$11.1M
Cap. Flow %
2.52%
Top 10 Hldgs %
100%
Holding
11
New
1
Increased
–
Reduced
–
Closed
–
Avg Time Held
3.6 years
Top 10 Avg Time Held
3 years
Top 20 Avg Time Held
3.6 years

Top Buys

Rank Stock Value
1
TMS
Teamshares Inc
TMS
+$11.1M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Miscellaneous 91.68%
2 Healthcare 6.27%
3 Financials 2.06%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
VEU icon
1
Vanguard FTSE All-World ex-US ETF
VEU
$66.9B
$272M 61.76%
3,243,484
– –
2024 Q3
7 quarters
VTV icon
2
Vanguard Morningstar Value ETF
VTV
$189B
$113M 25.77%
520,000
– –
2025 Q4
2 quarters
INDA icon
3
iShares MSCI India ETF
INDA
$5.83B
$18.3M 4.15%
369,600
– –
2022 Q4
14 quarters
ORIC icon
4
Oric Pharmaceuticals
ORIC
$1.32B
$10.7M 2.44%
989,410
– –
2020 Q4
22 quarters
TMS
5
Teamshares Inc
TMS
$413M
$9.04M 2.06%
+1,099,974
New +$11.1M
2026 Q2
0 quarters
FHTX icon
6
Foghorn Therapeutics
FHTX
$111M
$7.68M 1.75%
1,573,761
– –
2020 Q4
22 quarters
PMVP icon
7
PMV Pharmaceuticals
PMVP
$66.8M
$3.52M 0.8%
2,627,643
– –
2020 Q4
22 quarters
ALEC icon
8
Alector
ALEC
$218M
$2.63M 0.6%
1,307,858
– –
2020 Q4
22 quarters
SRZN icon
9
Surrozen
SRZN
$280M
$2.28M 0.52%
87,696
– –
2021 Q3
19 quarters
TNYA icon
10
Tenaya Therapeutics
TNYA
$84.7M
$751K 0.17%
1,015,705
– –
2021 Q3
19 quarters
SRZNW icon
11
DELISTED
Surrozen Inc Warrant
SRZNW
$2.82K ﹤0.01%
170,833
– –
2023 Q3
11 quarters

Similar funds

TAA
Turiya Advisors Asia Hong Kong $440M AUM 152.81% 1-Year Est. Return
DSA
Droms Strauss Advisors St. Louis, Missouri $441M AUM 25.07% 1-Year Est. Return
NCM
New Capital Management Houston, Texas $439M AUM 16.55% 1-Year Est. Return
OGM
OnyxPoint Global Management New York $439M AUM 52.19% 1-Year Est. Return
LWM
Long Walk Management Greenwich, Connecticut $441M AUM 30.08% 1-Year Est. Return
CSWG
Cardinal Strategic Wealth Guidance Louisville, Kentucky $441M AUM 25.22% 1-Year Est. Return
HS
HighVista Strategies Boston, Massachusetts $439M AUM 289.78% 1-Year Est. Return
MBFW
Morton Brown Family Wealth Allentown, Pennsylvania $441M AUM 20.82% 1-Year Est. Return

Euclidean Capital's Q2 2026 Portfolio in Review

As of Q2 2026, Euclidean Capital held 11 positions worth $440M, up 12% from $392M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Euclidean Capital's Q2 2026 filing shows 1 new position. Its largest new stake was Teamshares Inc: 1,099,974 shares worth $9.04M.

By sector, the portfolio is most concentrated in Miscellaneous at 92% of assets, down from 93% a quarter earlier, followed by Healthcare and Financials.

  • Euclidean Capital's largest Q2 2026 buy was Teamshares Inc: 1,099,974 shares worth $9.04M.
  • Euclidean Capital's ten largest holdings make up 100% of its $440M portfolio in Q2 2026.
  • Euclidean Capital opened 1 new position and closed 0 in Q2 2026.
  • Euclidean Capital's portfolio value rose 12% quarter-over-quarter to $440M.

Based on Euclidean Capital's 13F filing for Q2 2026, filed 14 Aug 2026.